Genetic test aims to match pancreatic cancer patients with best chemo
NCT ID NCT05475366
Summary
This study is testing a personalized approach to choose the first chemotherapy for people with advanced pancreatic cancer that has spread. Doctors will analyze the genetic makeup of a patient's tumor biopsy to predict which of two standard chemotherapy combinations might work better. The goal is to see if this matching leads to more patients having their tumors shrink compared to standard treatment selection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, PANCREATIC DUCTAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
CHU Robert Debré
RECRUITINGReims, 51092, France
Contact
-
Hôpital Beaujon
RECRUITINGClichy, 92210, France
Contact
-
Hôpital Claude Hurriez
RECRUITINGLille, 59037, France
Contact
-
Hôpital HENRI MONDOR
RECRUITINGCréteil, 94010, France
Contact
-
Hôpital PAUL BROUSSE 12 Avenue Paul Vaillant Couturier
NOT_YET_RECRUITINGVillejuif, 94800, France
Contact
-
Institut Curie
RECRUITINGSaint-Cloud, 92210, France
Contact
-
Institut Paoli-Calmettes
RECRUITINGMarseille, 13573, France
Contact
Conditions
Explore the condition pages connected to this study.